CAS: 1187990-87-9
Ref: IN-DA0096T2
| 5mg | 50.00 € | ||
| 10mg | 65.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
MK-8617
CAS:1187990-87-9
MK-8617 is an orally available HIF PHD1 3 pan-inhibitor, inhibiting PHD1/2/3 (IC50: 1.0/1.0/14 nM).
Formula:
C24H21N5O4
Purity:
100% - 99.63%
Color and Shape:
Solid
Molecular weight:
443.45
Ref: TM-T4106
| 5mg | 48.00 € | ||
| 10mg | 74.00 € | ||
| 25mg | 145.00 € | ||
| 50mg | 235.00 € | ||
| 100mg | 393.00 € | ||
| 200mg | 560.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
![N-[bis(4-methoxyphenyl)methyl]-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide](https://static.cymitquimica.com/products/10/thumb/F811127.jpg)
N-[bis(4-methoxyphenyl)methyl]-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide
CAS:1187990-87-9
Purity:
95%
Molecular weight:
443.4630126953125
Ref: 10-F811127
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 12 Mar 2025
MK 8617
CAS:1187990-87-9
Hypoxia inducible prolyl hydroxylase 1-3 (HIF PHD 1-3) inhibitor
Formula:
C24H21N5O4
Purity:
Min. 95%
Molecular weight:
443.45 g/mol
Ref: 3D-BM170837
| 10mg | 348.00 € | ||
| 50mg | 742.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
